Evidence map›Paper›PMID 30570525›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial).

Andréa Gosset, Camelia Protopopescu, Joseph Larmarange, Joanna Orne-Gliemann, Nuala McGrath, Deenan Pillay, François Dabis, Collins Iwuji, Sylvie Boyer

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andréa GossetINSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé, Traitement de l'Information Médicale, Aix Marseille University, Marseille, France.
Camelia ProtopopescuINSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé, Traitement de l'Information Médicale, Aix Marseille University, Marseille, France.
Joseph LarmarangeAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Joanna Orne-GliemannInserm, UMR 1219, Bordeaux Population Health Research Center, University Bordeaux, Bordeaux, France.
Nuala McGrathFaculty of Medicine and Faculty of Human, Social and Mathematical Sciences, University of Southampton, United Kingdom.
Deenan PillayAfrica Health Research Institute, KwaZulu-Natal, South Africa.
François DabisInserm, UMR 1219, Bordeaux Population Health Research Center, University Bordeaux, Bordeaux, France.
Collins IwujiDepartment of Global Health & Infection, Brighton and Sussex Medical School, Brighton, United Kingdom.
Sylvie BoyerINSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé, Traitement de l'Information Médicale, Aix Marseille University, Marseille, France.

Funding

Department of Health RP-2017-08-ST2-008Wellcome Trust
6 · The paper itself

Abstract

objectiveTo study retention in care (RIC) trajectories and associated factors in patients eligible for antiretroviral therapy (ART) in a universal test-and-treat setting (TasP trial, South Africa, 2012-2016).

designA cluster-randomized trial whereby individuals identified HIV positive after home-based testing were invited to initiate ART immediately (intervention) or following national guidelines (control).

methodsExiting care was defined as ≥3 months late for a clinic appointment, transferring elsewhere, or death. Group-based trajectory modeling was performed to estimate RIC trajectories over 18 months and associated factors in 777 ART-eligible patients.

resultsFour RIC trajectory groups were identified: (1) group 1 "remained" in care (reference, n = 554, 71.3%), (2) group 2 exited care then "returned" after [median (interquartile range)] 4 (3-9) months (n = 40, 5.2%), (3) group 3 "exited care rapidly" [after 4 (4-6) months, n = 98, 12.6%], and (4) group 4 "exited care later" [after 11 (9-13) months, n = 85, 10.9%]. Group 2 patients were less likely to have initiated ART within 1 month and more likely to be male, young (<29 years), without a regular partner, and to have a CD4 count >350 cells/mm. Group 3 patients were more likely to be women without social support, newly diagnosed, young, and less likely to have initiated ART within 1 month. Group 4 patients were more likely to be newly diagnosed and aged 39 years or younger.

conclusionsHigh CD4 counts at care initiation were not associated with a higher risk of exiting care. Prompt ART initiation and special support for young and newly diagnosed patients with HIV are needed to maximize RIC.

Indexed as

AdolescentAdultAnti-Retroviral AgentsFemaleHIV InfectionsHumansMaleMiddle AgedPatient ComplianceRetention in CareRural PopulationSocial SupportSouth AfricaYoung AdultAnti-Retroviral Agents

Identifiers

PMID30570525
PMCPMC6410969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.